104 related articles for article (PubMed ID: 17370127)
21. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs.
Jiang M; Wang B; Wang C; He B; Fan H; Guo TB; Shao Q; Gao L; Liu Y
J Cell Biochem; 2008 Jan; 103(1):321-34. PubMed ID: 17541946
[TBL] [Abstract][Full Text] [Related]
23. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
24. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
[TBL] [Abstract][Full Text] [Related]
25. Neoangiogenesis with endothelial precursors for the treatment of ischemia.
Sepúlveda P; Martinez-León J; García-Verdugo JM
Transplant Proc; 2007 Sep; 39(7):2089-94. PubMed ID: 17889103
[TBL] [Abstract][Full Text] [Related]
26. Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells.
He Y; Chang G; Zhan S; Song X; Wang X; Luo Y
Biochem Biophys Res Commun; 2008 Jun; 370(3):489-94. PubMed ID: 18395519
[TBL] [Abstract][Full Text] [Related]
27. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product.
Capiod JC; Tournois C; Vitry F; Sevestre MA; Daliphard S; Reix T; Nguyen P; Lefrère JJ; Pignon B
Vox Sang; 2009 Apr; 96(3):256-65. PubMed ID: 19207166
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens.
Fadini GP; de Kreutzenberg S; Albiero M; Coracina A; Pagnin E; Baesso I; Cignarella A; Bolego C; Plebani M; Nardelli GB; Sartore S; Agostini C; Avogaro A
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):997-1004. PubMed ID: 18276910
[TBL] [Abstract][Full Text] [Related]
30. [Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor].
Zhang HR; Xu CP; Chen FL; Bian XW
Yao Xue Xue Bao; 2008 Feb; 43(2):133-7. PubMed ID: 18507338
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic angiogenesis using bone marrow cells].
Ikeda U
Masui; 2007 Nov; 56 Suppl():S6-11. PubMed ID: 18051443
[No Abstract] [Full Text] [Related]
32. In vivo perfusion of human skin substitutes with microvessels formed by adult circulating endothelial progenitor cells.
Kung EF; Wang F; Schechner JS
Dermatol Surg; 2008 Feb; 34(2):137-46. PubMed ID: 18190540
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells.
Mieno S; Clements RT; Boodhwani M; Sodha NR; Ramlawi B; Bianchi C; Sellke FW
Ann Thorac Surg; 2008 Apr; 85(4):1361-6. PubMed ID: 18355528
[TBL] [Abstract][Full Text] [Related]
34. Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma.
Ria R; Piccoli C; Cirulli T; Falzetti F; Mangialardi G; Guidolin D; Tabilio A; Di Renzo N; Guarini A; Ribatti D; Dammacco F; Vacca A
Clin Cancer Res; 2008 Mar; 14(6):1678-85. PubMed ID: 18347168
[TBL] [Abstract][Full Text] [Related]
35. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
[TBL] [Abstract][Full Text] [Related]
37. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
[TBL] [Abstract][Full Text] [Related]
38. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation.
van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH
Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100
[TBL] [Abstract][Full Text] [Related]
39. [Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia].
Boda Z; Veréb Z; Rajnavölgyi E
Orv Hetil; 2006 Jun; 147(25):1155-60. PubMed ID: 16893130
[TBL] [Abstract][Full Text] [Related]
40. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.
Sieveking DP; Buckle A; Celermajer DS; Ng MK
J Am Coll Cardiol; 2008 Feb; 51(6):660-8. PubMed ID: 18261686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
